
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adrianne F. Pike, Tatiana Varanita, Maaike A. C. Herrebout, et al.
Glia (2021) Vol. 69, Iss. 6, pp. 1413-1428
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
Katja Badanjak, Sonja Fixemer, Semra Smajić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4676-4676
Open Access | Times Cited: 198
Katja Badanjak, Sonja Fixemer, Semra Smajić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4676-4676
Open Access | Times Cited: 198
Multiple system atrophy
Werner Poewe, Iva Stanković, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 161
Werner Poewe, Iva Stanković, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 161
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
Yunna Li, Yun Xia, Sijia Yin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 116
Yunna Li, Yun Xia, Sijia Yin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 116
The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Metabolic reprogramming and polarization of microglia in Parkinson’s disease: Role of inflammasome and iron
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 64
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 64
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 52
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 52
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 51
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 51
The link between neuroinflammation and the neurovascular unit in synucleinopathies
Qing Wang, Jialing Zheng, Sven Pettersson, et al.
Science Advances (2023) Vol. 9, Iss. 7
Open Access | Times Cited: 47
Qing Wang, Jialing Zheng, Sven Pettersson, et al.
Science Advances (2023) Vol. 9, Iss. 7
Open Access | Times Cited: 47
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Neuroinflammation and immunometabolism in neurodegenerative diseases
Neha Lonkar, Eicke Latz, Róisín M. McManus
Current Opinion in Neurology (2025) Vol. 38, Iss. 2, pp. 163-171
Closed Access | Times Cited: 2
Neha Lonkar, Eicke Latz, Róisín M. McManus
Current Opinion in Neurology (2025) Vol. 38, Iss. 2, pp. 163-171
Closed Access | Times Cited: 2
NLRP3 inflammasome in neurodegenerative disease
Faith L. Anderson, Karl Biggs, Brynn E. Rankin, et al.
Translational research (2022) Vol. 252, pp. 21-33
Open Access | Times Cited: 67
Faith L. Anderson, Karl Biggs, Brynn E. Rankin, et al.
Translational research (2022) Vol. 252, pp. 21-33
Open Access | Times Cited: 67
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Adrianne F. Pike, Francesca Longhena, Gaia Faustini, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 56
Adrianne F. Pike, Francesca Longhena, Gaia Faustini, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 56
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Giuseppe Arena, Karan Sharma, Gideon Agyeah, et al.
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 8, pp. 427-440
Open Access | Times Cited: 52
Giuseppe Arena, Karan Sharma, Gideon Agyeah, et al.
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 8, pp. 427-440
Open Access | Times Cited: 52
Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
Linh Thi Nhat Nguyen, Hữu Đạt Nguyễn, Yun Joong Kim, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 7, pp. 2117-2133
Open Access | Times Cited: 44
Linh Thi Nhat Nguyen, Hữu Đạt Nguyễn, Yun Joong Kim, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 7, pp. 2117-2133
Open Access | Times Cited: 44
Microglia in Parkinson’s Disease
Nadia Stefanova
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S105-S112
Open Access | Times Cited: 41
Nadia Stefanova
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S105-S112
Open Access | Times Cited: 41
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Qiu-Qin Han, Weidong Le
Neuroscience Bulletin (2023) Vol. 39, Iss. 5, pp. 832-844
Open Access | Times Cited: 38
Qiu-Qin Han, Weidong Le
Neuroscience Bulletin (2023) Vol. 39, Iss. 5, pp. 832-844
Open Access | Times Cited: 38
Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms
Nadia Stefanova, Gregor K. Wenning
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 6, pp. 334-346
Closed Access | Times Cited: 32
Nadia Stefanova, Gregor K. Wenning
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 6, pp. 334-346
Closed Access | Times Cited: 32
Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway
Pengfei Liu, Yunfeng Zhou, Jun-Zhuo Shi, et al.
Phytomedicine (2023) Vol. 115, pp. 154801-154801
Closed Access | Times Cited: 27
Pengfei Liu, Yunfeng Zhou, Jun-Zhuo Shi, et al.
Phytomedicine (2023) Vol. 115, pp. 154801-154801
Closed Access | Times Cited: 27
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 24
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 24
The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
Adrianne F. Pike, Ildikò Szabó, Robert Veerhuis, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 34
Adrianne F. Pike, Ildikò Szabó, Robert Veerhuis, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 34
Inflammasome Activation in Parkinson’s Disease
Shannon Jewell, Ashane M. Herath, Richard D. Gordon
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S113-S128
Open Access | Times Cited: 31
Shannon Jewell, Ashane M. Herath, Richard D. Gordon
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S113-S128
Open Access | Times Cited: 31
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Ran Zheng, Yiqun Yan, Shaobing Dai, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Ran Zheng, Yiqun Yan, Shaobing Dai, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20
The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
Jack Jonathan Maran, Moradeke M. Adesina, Colin Green, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101954-101954
Closed Access | Times Cited: 18
Jack Jonathan Maran, Moradeke M. Adesina, Colin Green, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101954-101954
Closed Access | Times Cited: 18